Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Data suggest that adjuvant human papillomavirus (HPV)-vaccination in women treated for cervical HPV diseases reduces recurrent disease. This study investigates adjuvant HPV-vaccination and the rate of recurrence in women undergoing surgery for vulvar high-grade squamous intraepithelial lesions (HSIL...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghelardi, Alessandro, Marrai, Roberto, Bogani, Giorgio, Sopracordevole, Francesco, Bay, Paola, Tonetti, Arianna, Lombardi, Stefania, Bertacca, Gloria, Joura, Elmar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911252/
https://www.ncbi.nlm.nih.gov/pubmed/33503866
http://dx.doi.org/10.3390/vaccines9020083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911252/
https://www.ncbi.nlm.nih.gov/pubmed/33503866
http://dx.doi.org/10.3390/vaccines9020083

Ejemplares similares